NCT03420911

Brief Summary

The aim of this study is to determine the level of pain and anxiety in patients who present to the emergency department with acute pain, and to investigate the effect of the standard analgesic treatment and an additional anxiolytic treatment on pain and anxiety.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2013

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2013

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
4.1 years until next milestone

First Submitted

Initial submission to the registry

January 16, 2018

Completed
20 days until next milestone

First Posted

Study publicly available on registry

February 5, 2018

Completed
Last Updated

February 5, 2018

Status Verified

February 1, 2018

Enrollment Period

6 months

First QC Date

January 16, 2018

Last Update Submit

February 1, 2018

Conditions

Keywords

painanxietyemergency departmentpain management

Outcome Measures

Primary Outcomes (2)

  • the change in pain levels

    the change in pain levels between groups on the 100mm visual analogue scale at 0-30th minutes

    30 minutes

  • the change in anxiety levels

    the change in anxiety levels between groups on the 100mm visual analogue scale at 0-30th minutes

    30 minutes

Secondary Outcomes (3)

  • the need for rescue treatment

    120 minutes

  • the rate of the request for the same treatment

    120 minutes

  • the comparison of the pain and anxiety change on the visual analogue scale

    120 minutes

Study Arms (2)

dexketoprofen trometamol group

ACTIVE COMPARATOR

Received the study drugs in 100 mL of normal saline within 5 minutes. The dexketoprofen trometamol dose was 50 mg

Drug: dexketoprofen trometamol

dexketoprofen trometamol plus midazolam group

ACTIVE COMPARATOR

Received the study drugs in 100 mL of normal saline within 5 minutes. The dexketoprofen trometamol dose was 50 mg and the midazolam dose was 1 mg.

Drug: dexketoprofen trometamolDrug: Midazolam

Interventions

dexketoprofen trometamol groupdexketoprofen trometamol plus midazolam group
dexketoprofen trometamol plus midazolam group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The patients who presented to the emergency department with acute pain
  • Who accepted to include the study
  • Who were older than 18 years old

You may not qualify if:

  • Patients who refused to participate to the study
  • History of allergy to any of the study drugs
  • Pregnancy
  • Younger than 18 years old
  • Chronic pain
  • Antidepressant or anxiolytic drug use
  • Advanced kidney or liver failure
  • Use of analgesics within 6 hours before presentation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (9)

  • Tanabe P, Buschmann M. A prospective study of ED pain management practices and the patient's perspective. J Emerg Nurs. 1999 Jun;25(3):171-7. doi: 10.1016/s0099-1767(99)70200-x.

    PMID: 10346837BACKGROUND
  • Karwowski-Soulie F, Lessenot-Tcherny S, Lamarche-Vadel A, Bineau S, Ginsburg C, Meyniard O, Mendoza B, Fodella P, Vidal-Trecan G, Brunet F. Pain in an emergency department: an audit. Eur J Emerg Med. 2006 Aug;13(4):218-24. doi: 10.1097/01.mej.0000217975.31342.13.

    PMID: 16816586BACKGROUND
  • Craven P, Cinar O, Madsen T. Patient anxiety may influence the efficacy of ED pain management. Am J Emerg Med. 2013 Feb;31(2):313-8. doi: 10.1016/j.ajem.2012.08.009. Epub 2012 Sep 13.

    PMID: 22981626BACKGROUND
  • Ocanez KL, McHugh RK, Otto MW. A meta-analytic review of the association between anxiety sensitivity and pain. Depress Anxiety. 2010 Aug;27(8):760-7. doi: 10.1002/da.20681.

    PMID: 20336798BACKGROUND
  • Ethier C, Burry L, Martinez-Motta C, Tirgari S, Jiang D, McDonald E, Granton J, Cook D, Mehta S; Canadian Critical Care Trials Group. Recall of intensive care unit stay in patients managed with a sedation protocol or a sedation protocol with daily sedative interruption: a pilot study. J Crit Care. 2011 Apr;26(2):127-32. doi: 10.1016/j.jcrc.2010.08.003.

    PMID: 20889289BACKGROUND
  • Behrbalk E, Halpern P, Boszczyk BM, Parks RM, Chechik O, Rosen N, Shapira A, Merose O, Uri O. Anxiolytic medication as an adjunct to morphine analgesia for acute low back pain management in the emergency department: a prospective randomized trial. Spine (Phila Pa 1976). 2014 Jan 1;39(1):17-22. doi: 10.1097/BRS.0000000000000038.

    PMID: 24270933BACKGROUND
  • Bonett DG, Price RM. Statistical inference for a linear function of medians: confidence intervals, hypothesis testing, and sample size requirements. Psychol Methods. 2002 Sep;7(3):370-83. doi: 10.1037/1082-989x.7.3.370.

    PMID: 12243307BACKGROUND
  • Mok LC, Lee IF. Anxiety, depression and pain intensity in patients with low back pain who are admitted to acute care hospitals. J Clin Nurs. 2008 Jun;17(11):1471-80. doi: 10.1111/j.1365-2702.2007.02037.x. Epub 2008 Feb 19.

    PMID: 18298508BACKGROUND
  • Oktay C, Eken C, Ozbek K, Ankun G, Eray O, Avci AB. Pain perception of patients predisposed to anxiety and depressive disorders in emergency department. Pain Manag Nurs. 2008 Dec;9(4):150-3, 153.e1-3. doi: 10.1016/j.pmn.2008.06.002.

    PMID: 19041612BACKGROUND

Related Links

MeSH Terms

Conditions

Acute PainAnxiety DisordersPainEmergenciesAgnosia

Interventions

dexketoprofen trometamolMidazolam

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental DisordersDisease AttributesPathologic ProcessesPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Intervention Hierarchy (Ancestors)

BenzodiazepinesBenzazepinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic Compounds

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Sequenced study medications were prepared by a nurse, and another nurse administered the medications.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants were randomly assigned into two groups with a 1:1 allocation following simple randomization procedures by a program generating an online random number
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 16, 2018

First Posted

February 5, 2018

Study Start

June 1, 2013

Primary Completion

December 1, 2013

Study Completion

December 1, 2013

Last Updated

February 5, 2018

Record last verified: 2018-02